AstraZeneca KK:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AstraZeneca KK - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10939
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AstraZeneca KK (AstraZeneca) a subsidiary of AstraZeneca Plc is a drug company that provides prescription medicines. The company offers products such as akoreto, arimidex, iressa, inderal, casodex, crestor, and other tablets. It offers products for oncology, cardiovascular and metabolic diseases, respiratory and autoimmune diseases. AstraZeneca also offers treatment of EGFR T790M mutation positive for non-small cell lung cancer. The company has presence in Sapporo, Tokyo, Saitama, Osaka, Hiroshima and Fukuoka. It operates through its factory and distribution center located in Maibara and Ibaraki. AstraZeneca is headquartered in Osaka, Japan.

AstraZeneca KK – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AstraZeneca KK, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AstraZeneca KK, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 10
AstraZeneca Enters Into Co-Promotion Agreement With Ono Pharma For Dapagliflozin 11
AstraZeneca Enters Into Agreement With Bristol-Myers To Commercialize Dapagliflozin In Japan 12
Acquisition 13
AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 13
AstraZeneca KK – Key Competitors 15
AstraZeneca KK – Key Employees 16
AstraZeneca KK – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
AstraZeneca KK, Pharmaceuticals & Healthcare, Key Facts 2
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AstraZeneca KK, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AstraZeneca KK, Deals By Therapy Area, 2012 to YTD 2018 8
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 10
AstraZeneca Enters Into Co-Promotion Agreement With Ono Pharma For Dapagliflozin 11
AstraZeneca Enters Into Agreement With Bristol-Myers To Commercialize Dapagliflozin In Japan 12
AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 13
AstraZeneca KK, Key Competitors 15
AstraZeneca KK, Key Employees 16
AstraZeneca KK, Other Locations 17

List of Figures
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[AstraZeneca KK:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Turisthotel d.d.:企業の戦略・SWOT・財務情報
    Turisthotel d.d. - Strategy, SWOT and Corporate Finance Report Summary Turisthotel d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kuros Biosciences AG (KURN):企業の財務・戦略的SWOT分析
    Kuros Biosciences AG (KURN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • West Corporation:企業の戦略的SWOT分析
    West Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Helm AG:企業の戦略・SWOT・財務情報
    Helm AG - Strategy, SWOT and Corporate Finance Report Summary Helm AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Alabama Municipal Electric Authority:電力:M&Aディール及び事業提携情報
    Summary Alabama Municipal Electric Authority (AMEA) is a not-for-profit publicly-owned electric utility that generates, procures, and supplies power. The authority generates electricity from sources such as gas and solar. AMEA procures electricity from open market and South Carolina Public Service A …
  • Polpharma SA-製薬・医療分野:企業M&A・提携分析
    Summary Polpharma SA (Polpharma) undertakes the research, manufacture and marketing of generic drugs, prescription drugs and over the counter medications. It provides drugs in cardiology, gastroenterology and neurology areas. The company also manufactures over the counter (OTC) medications, dietary …
  • SonarMed Inc:医療機器:M&Aディール及び事業提携情報
    Summary SonarMed Inc (SonarMed) is a medical device company that develops endotrachael systems used for the inhalation and ventilation assistance patients. The company offers products such as artificial respiratory, endotrachael tubes, biomedical acoustics, SonarMed Airwave, medical devices, disposa …
  • GS Yuasa Corporation (6674):企業の財務・戦略的SWOT分析
    GS Yuasa Corporation (6674) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • China Grand Pharmaceutical and Healthcare Holdings Ltd (512):企業の財務・戦略的SWOT分析
    Summary China Grand Pharmaceutical and Healthcare Holdings Ltd (China Grand) is an investment holding company that develops, manufacture and distributes pharmaceutical preparations, medical devices and pharmaceutical intermediates, specialized raw materials, and healthcare products. The company prov …
  • Kolon Life Science Inc (102940):製薬・医療:M&Aディール及び事業提携情報
    Summary Kolon Life Science Inc (KLS) focuses on research and development, manufacture and commercialization of pharmaceutical products and active pharmaceutical ingredients (APIs). It develops innovative cell and gene therapeutics. The company's lead product is Invossa, the first cell-mediated gene …
  • Rush Enterprises, Inc.:企業の戦略・SWOT・財務情報
    Rush Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rush Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • VAALCO Energy Inc (EGY):企業の財務・戦略的SWOT分析
    VAALCO Energy Inc (EGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ivanhoe Mines Ltd:企業のM&A・事業提携・投資動向
    Ivanhoe Mines Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ivanhoe Mines Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • MacroGenics Inc (MGNX):企業の財務・戦略的SWOT分析
    MacroGenics Inc (MGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • The Capital Group Companies, Inc.:企業の戦略・SWOT・財務情報
    The Capital Group Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Capital Group Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • The Abraaj Group-エネルギー分野:企業M&A・提携分析
    Summary The Abraaj Group (Abraaj) is a financial service provider that offers private equity, investment and credit strategies for real estate operations. The company helps companies in their operational improvements, management incentives, optimization of capital structure and the use of leverage. …
  • GulfMark Offshore Inc (GLF):石油・ガス:M&Aディール及び事業提携情報
    Summary GulfMark Offshore Inc (GulfMark Offshore), formerly New GulfMark Offshore Inc is an oil and gas company that offers oil and gas, and marine transportation services. The company owns, operates, and manages fleet of vessels offering marine specialty services to offshore oil and natural gas dri …
  • Silver Bull Resources, Inc.:企業の戦略・SWOT・財務分析
    Silver Bull Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Silver Bull Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Halozyme Therapeutics Inc (HALO):企業の財務・戦略的SWOT分析
    Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • POSCO:企業のM&A・事業提携・投資動向
    POSCO - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's POSCO Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆